Literature DB >> 15563306

Histological quantitation of tumour angiogenesis.

Stephen B Fox1, Adrian L Harris.   

Abstract

Tumours establish their blood supply via a number of processes in addition to angiogenesis. These include vasculogenesis, vascular remodelling, intussusception and possibly vascular mimicry in certain tumours. The mainstay of the assessment of tumour vascularity has been counting the number of immunohistochemically identified microvessels in vascular hot spots. Nevertheless, several other techniques are available, including Chalkley counting, vascular grade and the use of image analysis systems. Angiogenic activity can furthermore be assessed in histological samples by measuring the molecules involved in the establishment of the tumour vasculature, including angiogenic growth factors and their receptors, cell adhesion molecules, proteases and markers of activated, proliferating, cytokine stimulated or angiogenic vessels, such as CD105. Measuring the maturity of vessels may give an indication of the proportion of the tumour vasculature that is functional. Other reagents that can identify hypoxia-activated pathways are also being developed. The histological assessment of tumour vascularity is mainly used in the research setting but may also have applications in the clinic if appropriate methodology and trained observers perform the studies. Gene arrays may be able to provide an angiogenesis profile. Continued study into the processes involved in generating a tumour blood supply is likely to identify new markers that may be more accurate measures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15563306     DOI: 10.1111/j.1600-0463.2004.apm11207-0803.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  45 in total

1.  Three-dimensional image quantification as a new morphometry method for tissue engineering.

Authors:  Julie A Rytlewski; Laura R Geuss; Chinedu I Anyaeji; Evan W Lewis; Laura J Suggs
Journal:  Tissue Eng Part C Methods       Date:  2012-02-17       Impact factor: 3.056

2.  Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

Authors:  Joline S W Lind; Martijn R Meijerink; Anne-Marie C Dingemans; Cornelis van Kuijk; Michel C Ollers; Dirk de Ruysscher; Pieter E Postmus; Egbert F Smit
Journal:  Eur Radiol       Date:  2010-07-13       Impact factor: 5.315

3.  Esophageal squamous cell carcinoma: assessing tumor angiogenesis using multi-slice CT perfusion imaging.

Authors:  Tao Song; Yu-Guang Shen; Na-Na Jiao; Xin-Hui Li; Hong-Tao Hu; Jin-Rong Qu; Xue-Jun Chen; Wen Feng; Xun Zhang; Hai-Liang Li
Journal:  Dig Dis Sci       Date:  2012-04-03       Impact factor: 3.199

4.  Immunohistochemical study of stromal and vascular components of tonsillar polyps: high endothelial venules as participants of the polyp's lymphoid tissue.

Authors:  Icléia Barreto; Ana Flávia Costa; Marília Trierveiler Martins; Cristiane Furuse; Vera Cavalcanti de Araújo; Albina Altemani
Journal:  Virchows Arch       Date:  2011-05-12       Impact factor: 4.064

Review 5.  Convergence of nanotechnology and cancer prevention: are we there yet?

Authors:  David G Menter; Sherri L Patterson; Craig D Logsdon; Scott Kopetz; Anil K Sood; Ernest T Hawk
Journal:  Cancer Prev Res (Phila)       Date:  2014-07-24

6.  Gas challenge-blood oxygen level-dependent (GC-BOLD) MRI in the rat Novikoff hepatoma model.

Authors:  Yang Guo; Ning Jin; Rachel Klein; Jodi Nicolai; Guang-Yu Yang; Reed A Omary; Andrew C Larson
Journal:  Magn Reson Imaging       Date:  2011-11-04       Impact factor: 2.546

7.  Expression of a novel endothelial marker, C-type lectin 14A, in epithelial ovarian cancer and its prognostic significance.

Authors:  S Krishna Priya; Kishore Kumar; K R Hiran; M R Bindhu; Rohit P Nagare; D K Vijaykumar; T S Ganesan
Journal:  Int J Clin Oncol       Date:  2016-08-27       Impact factor: 3.402

8.  Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities.

Authors:  Radu O Minea; Corey M Helchowski; Samuel J Zidovetzki; Fritz K Costa; Stephen D Swenson; Francis S Markland
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

9.  Canine classical seminoma: a specific malignant type with human classifications is highly correlated with tumor angiogenesis.

Authors:  Jong-Hyuk Kim; Chi-Ho Yu; Ji-Young Yhee; Keum-Soon Im; Na-Hyun Kim; Jung-Hyang Sur
Journal:  BMC Cancer       Date:  2010-05-28       Impact factor: 4.430

10.  Inhibitory effects of anti-VEGF antibody on the growth and angiogenesis of estrogen-induced pituitary prolactinoma in Fischer 344 Rats: animal model of VEGF-targeted therapy for human endocrine tumors.

Authors:  Katsuhiro Miyajima; Susumu Takekoshi; Johbu Itoh; Kochi Kakimoto; Takashi Miyakoshi; Robert Yoshiyuki Osamura
Journal:  Acta Histochem Cytochem       Date:  2010-04-07       Impact factor: 1.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.